How is the interventional treatment plan for liver cancer formulated? Uncovering the interventional treatment plan for liver cancer

Hepatocellular carcinoma is one of the common malignant tumors that seriously endangers human life and health! Its morbidity and mortality have a tendency to gradually increase. Interventional therapy has become a powerful tool to assist its treatment. Therefore, it is becoming increasingly important to formulate a reasonable interventional therapy plan.

When formulating an interventional treatment plan, many relevant factors should be considered comprehensively, such as the size and shape of the tumor, blood supply, size and location of the tumor thrombus, arteriovenous shunt, liver function, blood count, physical potential, etc., to determine whether the patient is suitable for interventional treatment. If interventional treatment is the preferred option, the corresponding interventional treatment plan should be selected according to the patient's specific angiography conditions. If angiography finds that the liver cancer is a nodular type with low blood supply, the interventional treatment effect is not ideal, and other therapies should be recommended. Multi-slice spiral CT (MSCT) is one of the major advances in CT technology in recent years. Due to its fast scanning speed, it can not only display relevant information about tumors and their complications, and improve the detection rate of lesions, but also display the anatomy and course of blood vessels, the size, number, degree of enhancement and distribution range of tumors, the presence or absence of portal vein tumor thrombus, the location of formation, arteriovenous fistula, the presence or absence of obstructive jaundice and the amount of ascites, the presence or absence of abdominal lymph node enlargement, and whether the inferior vena cava is invaded. These information are of great guiding significance for judging whether interventional treatment is suitable and formulating a reasonable treatment plan. For those who are eligible, preoperative MSCT is of great guiding significance for formulating interventional treatment plans for liver cancer, performing targeted intubation, reducing the difficulty of finding target blood vessels, shortening operation time, and reducing the radiation dose of patients and interventional operators.

I believe that with the assistance of reasonable and effective interventional therapy, the possibility of curing hepatocellular carcinoma will become increasingly greater!